Cardium Therapeutics today announced that Chairman & CEO Christopher J. Reinhard will be giving a presentation at the Rodman & Renshaw Annual Healthcare Investment Conference on Monday, September 10, 2012, at 3:15 p.m. Eastern Time. The conference is being held September 9-11, 2012, at the Waldorf-Astoria Hotel in New York City.
An audio webcast of the company's presentation will be available both live and by replay at http://www.wsw.com/webcast/rrshq22/cxm as well as the Investors section of Cardium's website at http://phx.corporate-ir.net/phoenix.zhtml?c=77949&p=irol-calendar. An updated investor presentation is now available on Cardium's website at http://phx.corporate-ir.net/phoenix.zhtml?c=77949&p=irol-presentations.
Cardium Therapeutics is a health sciences and regenerative medicine company focused on acquiring and strategically developing new and innovative products and businesses to address significant unmet medical needs. Comprised of large-market opportunities with definable pathways to commercialization, partnering, and other economic monetizations, Cardium's current portfolio includes the Tissue Repair Company, Cardium Biologics, and the company's in-house MedPodium Health Sciences healthy lifestyle product platform.
To learn more about the company, visit www.cardiumthx.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html